Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug
Shuang Xiao(Chongqing Medical University), Mingli Peng(Chongqing Medical University), Peng Hu(Chongqing Medical University), Huadong Tang(Capital Medical University), Neng Shen(Chongqing University), Yanhong Deng(Sun Yat-sen University), Yong Sun, Hong Ren(Xuzhou Medical College)
Cited by 11
Related Papers
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402